Cargando…

A role of peroxisome proliferator‐activated receptor γ in non‐alcoholic fatty liver disease

Non‐alcoholic fatty liver disease is becoming a major health burden, as prevalence increases and there are no approved treatment options. Thiazolidinediones target the nuclear receptor peroxisome proliferator‐activated receptor γ (PPARγ) and have been investigated in several clinical trials for thei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skat‐Rørdam, Josephine, Højland Ipsen, David, Lykkesfeldt, Jens, Tveden‐Nyborg, Pernille
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	MINIREVIEWS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850367/ https://www.ncbi.nlm.nih.gov/pubmed/30561132 http://dx.doi.org/10.1111/bcpt.13190

Ejemplares similares

Dietary Long-Chain Fatty Acids Accelerate Metabolic Dysfunction in Guinea Pigs with Non-Alcoholic Steatohepatitis
por: Pedersen, Kamilla, et al.
Publicado: (2023)

Differential Effects of Dietary Components on Glucose Intolerance and Non-Alcoholic Steatohepatitis
por: Skat-Rørdam, Josephine, et al.
Publicado: (2021)

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
por: Ipsen, David Højland, et al.
Publicado: (2018)

Does Vitamin C Deficiency Promote Fatty Liver Disease Development?
por: Ipsen, David Højland, et al.
Publicado: (2014)

Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact
por: Ipsen, David Højland, et al.
Publicado: (2021)

Modelling Nonalcoholic Steatohepatitis In Vivo—A Close Transcriptomic Similarity Supports the Guinea Pig Disease Model
por: Skat-Rørdam, Josephine, et al.
Publicado: (2021)

Vitamin C Deficiency May Delay Diet-Induced NASH Regression in the Guinea Pig
por: Skat-Rørdam, Josephine, et al.
Publicado: (2021)

Atorvastatin and Vitamin E Accelerates NASH Resolution by Dietary Intervention in a Preclinical Guinea Pig Model
por: Klaebel, Julie Hviid, et al.
Publicado: (2019)

Vitamin C Deficiency Exacerbates Dysfunction of Atherosclerotic Coronary Arteries in Guinea Pigs Fed a High-Fat Diet
por: Skovsted, Gry Freja, et al.
Publicado: (2022)

High-fat but not sucrose intake is essential for induction of dyslipidemia and non-alcoholic steatohepatitis in guinea pigs
por: Ipsen, David Højland, et al.
Publicado: (2016)

The Pharmacokinetics of Vitamin C
por: Lykkesfeldt, Jens, et al.
Publicado: (2019)

Regulation of Vitamin C Homeostasis during Deficiency
por: Lindblad, Maiken, et al.
Publicado: (2013)

Does Vitamin C Deficiency Affect Cognitive Development and Function?
por: Hansen, Stine Normann, et al.
Publicado: (2014)

l-dehydroascorbic acid can substitute l-ascorbic acid as dietary vitamin C source in guinea pigs
por: Frikke-Schmidt, Henriette, et al.
Publicado: (2015)

The development of nonalcoholic steatohepatitis is subjected to breeder dependent variation in guinea pigs
por: Ipsen, D. H., et al.
Publicado: (2021)

Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?
por: Zisser, Alexandra, et al.
Publicado: (2021)

Vitamin C Deficiency Reduces Muscarinic Receptor Coronary Artery Vasoconstriction and Plasma Tetrahydrobiopterin Concentration in Guinea Pigs
por: Skovsted, Gry Freja, et al.
Publicado: (2017)

Chronic Vitamin C Deficiency Promotes Redox Imbalance in the Brain but Does Not Alter Sodium-Dependent Vitamin C Transporter 2 Expression
por: Paidi, Maya D., et al.
Publicado: (2014)

Prenatal vitamin C deficiency results in differential levels of oxidative stress during late gestation in foetal guinea pig brains
por: Paidi, Maya D., et al.
Publicado: (2014)

Dietary Intervention Accelerates NASH Resolution Depending on Inflammatory Status with Minor Additive Effects on Hepatic Injury by Vitamin E Supplementation
por: Klaebel, Julie Hviid, et al.
Publicado: (2020)

Spatial Memory Dysfunction Induced by Vitamin C Deficiency Is Associated with Changes in Monoaminergic Neurotransmitters and Aberrant Synapse Formation
por: Hansen, Stine Normann, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Early Life Vitamin C Deficiency Does Not Alter Morphology of Hippocampal CA1 Pyramidal Neurons or Markers of Synaptic Plasticity in a Guinea Pig Model
por: Hansen, Stine N., et al.
Publicado: (2018)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update
por: Sofogianni, Areti, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

Growing challenge of post-liver transplantation non-alcoholic fatty liver disease
por: Kalogirou, Maria Styliani, et al.
Publicado: (2022)

Vitamin C Deficiency in the Young Brain—Findings from Experimental Animal Models †
por: Tveden-Nyborg, Pernille
Publicado: (2021)

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
por: Wong, Carrie R, et al.
Publicado: (2016)

Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Said, Adnan, et al.
Publicado: (2017)

Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
por: Yousef, Mohamad H, et al.
Publicado: (2017)

Racial differences in prevalence and severity of non-alcoholic fatty liver disease
por: Bonacini, Maurizio, et al.
Publicado: (2021)

Therapies for non-alcoholic fatty liver disease: A 2022 update
por: Shen, Katie, et al.
Publicado: (2022)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
por: Mato, José M, et al.
Publicado: (2019)

Relationship between non-alcoholic fatty liver disease and coronary heart disease
por: Arslan, Ugur, et al.
Publicado: (2020)

Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome
por: Sheng, Wei, et al.
Publicado: (2022)

Research progress on the mitochondrial mechanism of age-related non-alcoholic fatty liver
por: Wang, Dan, et al.
Publicado: (2023)

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
por: Chackelevicius, Carla Melisa, et al.
Publicado: (2016)

Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view
por: Chen, Hui-Ting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_331v8mt5a2mabuf4q8b2lhaddm